![Table 3 from Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study | Semantic Scholar Table 3 from Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/44048ce67821088ef01f8a33e53217b1be0795b0/3-Table3-1.png)
Table 3 from Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study | Semantic Scholar
![MedRewind on X: "PPIs like omeprazole, lansoprazole, rabeprazole, pantoprazole, esomeprazole, or dexlansoprazole https://t.co/ibBterx8Q5" / X MedRewind on X: "PPIs like omeprazole, lansoprazole, rabeprazole, pantoprazole, esomeprazole, or dexlansoprazole https://t.co/ibBterx8Q5" / X](https://pbs.twimg.com/media/Ee0G3GdUcAIWwn6.jpg:large)
MedRewind on X: "PPIs like omeprazole, lansoprazole, rabeprazole, pantoprazole, esomeprazole, or dexlansoprazole https://t.co/ibBterx8Q5" / X
![Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory | Scientific Reports Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-53622-3/MediaObjects/41598_2019_53622_Fig1_HTML.png)